Jing An

Title(s)Adjunct Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    McGill UniversityPhD1997Exp. Medicine
    China Medical UniversityMD1984Medicine

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Development of a new therapeutic for directing target-specific stem cell migration and treatment
    CIRM DISC2Nov 1, 2021 - Apr 30, 2024
    Role: Co-Principal Investigator
    Structures and Interactions of Chemokine Receptors
    NIH R01GM057761May 1, 2018 - May 31, 2026
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Biological and mutational analyses of CXCR4-antagonist interactions and design of new antagonistic analogs. Biosci Rep. 2023 12 22; 43(12). Meng Q, Zhu R, Mao Y, Zhu S, Wu Y, Huang LSM, Ciechanover A, An J, Xu Y, Huang Z. PMID: 38131305.
      View in: PubMed   Mentions:    Fields:    
    2. A Chemical Strategy for the Degradation of the Main Protease of SARS-CoV-2 in Cells. J Am Chem Soc. 2023 12 20; 145(50):27248-27253. Sang X, Wang J, Zhou J, Xu Y, An J, Warshel A, Huang Z. PMID: 38064654.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Elucidation of the α-Ketoamide Inhibition Mechanism: Revealing the Critical Role of the Electrostatic Reorganization Effect of Asp17 in the Active Site of the 20S Proteasome. ACS Catalysis. 2023; 21(13):14368–14376. Zhou J, Sang X, Wang J, Xu Y, An J, Chu ZT, Saha A, Warshel A, Huang Z. View Publication.
    4. A novel mechanism of 6-methoxydihydroavicine in suppressing ovarian carcinoma by disrupting mitochondrial homeostasis and triggering ROS/ MAPK mediated apoptosis. Front Pharmacol. 2023; 14:1093650. Zhang H, Shangguan F, Zhang L, Ma N, Song S, Ma L, Liu C, Liu M, An J, Li H, Cao Q. PMID: 37214469; PMCID: PMC10196025.
      View in: PubMed   Mentions: 1  
    5. CXCR4 Recognition by L- and D-Peptides Containing the Full-Length V3 Loop of HIV-1 gp120. Viruses. 2023 04 28; 15(5). Zhu R, Sang X, Zhou J, Meng Q, Huang LSM, Xu Y, An J, Huang Z. PMID: 37243169; PMCID: PMC10221217.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method. Viruses. 2023 03 30; 15(4). Zhang H, Liang B, Sang X, An J, Huang Z. PMID: 37112871; PMCID: PMC10143255.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    7. A novel mechanism of cannabidiol in suppressing ovarian cancer through LAIR-1 mediated mitochondrial dysfunction and apoptosis. Environ Toxicol. 2023 May; 38(5):1118-1132. Ma L, Zhang H, Liu C, Liu M, Shangguan F, Liu Y, Yang S, Li H, An J, Song S, Cao Q, Qu G. PMID: 36810933.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    8. A synthetic bivalent peptide ligand of EphB4 with potent agonistic activity. Eur J Med Chem. 2022 Dec 15; 244:114804. Fan T, Liang B, Nie L, Wang J, Zhang H, Ciechanover A, Xu Y, An J, Huang Z. PMID: 36208510.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop. Eur J Med Chem. 2022 Dec 15; 244:114797. Zhu R, Meng Q, Zhang H, Zhang G, Huang LSM, Xu Y, Schooley RT, An J, Huang Z. PMID: 36270088; PMCID: PMC10150781.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    10. Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir. Biochem Biophys Rep. 2022 Jul; 30:101283. Zhang H, Zhang XQ, Huang LS, Fang X, Khan M, Xu Y, An J, Schooley RT, Huang Z. PMID: 35647321; PMCID: PMC9136107.
      View in: PubMed   Mentions:
    11. 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Caspase-dependent cell death in pancreatic cancer cells through the disruption of oxaloacetic acid metabolism and accumulation of reactive oxygen species. Phytomedicine. 2022 Jul 20; 102:154164. Ma N, Shangguan F, Zhou H, Huang H, Lei J, An J, Jin G, Zhuang W, Zhou S, Wu S, Xia H, Yang H, Lan L. PMID: 35597026.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    12. A fragment integrational approach to GPCR inhibition: Identification of a high affinity small molecule CXCR4 antagonist. Eur J Med Chem. 2022 Mar 05; 231:114150. Fang X, Meng Q, Zhang H, Fang X, Huang LS, Zhang X, Schooley RT, Ciechanover A, An J, Xu Y, Huang Z. PMID: 35124530.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    13. Trends in application of advancing computational approaches in GPCR ligand discovery. Exp Biol Med (Maywood). 2021 05; 246(9):1011-1024. Zhu S, Wu M, Huang Z, An J. PMID: 33641446; PMCID: PMC8113737.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. A new class of α-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities. Eur J Med Chem. 2021 Apr 05; 215:113267. Wang J, Liang B, Chen Y, Fuk-Woo Chan J, Yuan S, Ye H, Nie L, Zhou J, Wu Y, Wu M, Huang LS, An J, Warshel A, Yuen KY, Ciechanover A, Huang Z, Xu Y. PMID: 33639344; PMCID: PMC7873610.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    15. A novel small molecule CXCR4 antagonist potently mobilizes hematopoietic stem cells in mice and monkeys. Stem Cell Res Ther. 2021 01 07; 12(1):17. Fang X, Fang X, Mao Y, Ciechanover A, Xu Y, An J, Huang Z. PMID: 33413613; PMCID: PMC7791974.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    16. Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migration. Proc Natl Acad Sci U S A. 2020 12 08; 117(49):31177-31188. Lee JP, Zhang R, Yan M, Duggineni S, Wakeman DR, Niles WL, Feng Y, Chen J, Hamblin MH, Han EB, Gonzalez R, Fang X, Zhu Y, Wang J, Xu Y, Wenger DA, Seyfried TN, An J, Sidman RL, Huang Z, Snyder EY. PMID: 33219123; PMCID: PMC7733796.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    17. Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry. ACS Med Chem Lett. 2020 Nov 12; 11(11):2318-2324. Ma H, Wang H, Li M, Barreto-de-Souza V, Reinecke BA, Gunta R, Zheng Y, Kang G, Nassehi N, Zhang H, An J, Selley DE, Hauser KF, Zhang Y. PMID: 33214847; PMCID: PMC7667867.
      View in: PubMed   Mentions: 4  
    18. LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway. Aging (Albany NY). 2020 09 05; 12(16):16142-16154. Liu Y, Ma L, Shangguan F, Zhao X, Wang W, Gao Z, Zhou H, Qu G, Huang Y, An J, Xue J, Yang S, Cao Q. PMID: 32628130; PMCID: PMC7485720.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    19. Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists. Eur J Med Chem. 2020 Aug 15; 200:112410. Fang X, Meng Q, Zhang H, Liang B, Zhu S, Wang J, Zhang C, Huang LS, Zhang X, Schooley RT, An J, Xu Y, Huang Z. PMID: 32492596.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    20. Niclosamide inhibits ovarian carcinoma growth by interrupting cellular bioenergetics. J Cancer. 2020; 11(12):3454-3466. Shangguan F, Liu Y, Ma L, Qu G, Lv Q, An J, Yang S, Lu B, Cao Q. PMID: 32284741; PMCID: PMC7150452.
      View in: PubMed   Mentions: 14  
    21. Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors. Exp Biol Med (Maywood). 2020 03; 245(5):477-485. Zhang C, Zhu R, Cao Q, Yang X, Huang Z, An J. PMID: 32019336; PMCID: PMC7082890.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    22. Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer. RSC Med Chem. 2020 Jan 01; 11(1):125-131. Reinecke BA, Kang G, Zheng Y, Obeng S, Zhang H, Selley DE, An J, Zhang Y. PMID: 33479612; PMCID: PMC7451026.
      View in: PubMed   Mentions: 4  
    23. Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4. Molecules. 2019 Aug 13; 24(16). Zhu S, Meng Q, Schooley RT, An J, Xu Y, Huang Z. PMID: 31412600; PMCID: PMC6720714.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    24. A novel dimeric CXCR4 antagonist synergizes with chemotherapy in acute myeloid leukaemia by mobilizing leukaemic cells from their associated bone marrow niches. Br J Haematol. 2019 10; 187(1):e11-e15. Huang Y, Huang Z, An J, Xu Y. PMID: 31388999.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    25. Pharmacokinetics of a novel microtubule inhibitor mHA11 in rats. Chem Biol Interact. 2019 Aug 01; 308:235-243. Yang S, Zhu Y, Fang X, Xu Y, Huang Y, An J, Huang Z. PMID: 31145889.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    26. The chemical biology of apoptosis: Revisited after 17 years. Eur J Med Chem. 2019 Sep 01; 177:63-75. Yang S, Mao Y, Zhang H, Xu Y, An J, Huang Z. PMID: 31129454.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    27. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors. Molecules. 2019 Apr 13; 24(8). Zhu S, Zhang C, Huang LS, Zhang XQ, Xu Y, Fang X, Zhou J, Wu M, Schooley RT, Huang Z, An J. PMID: 31013906; PMCID: PMC6514826.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    28. High affinity CXCR4 inhibitors generated by linking low affinity peptides. Eur J Med Chem. 2019 Jun 15; 172:174-185. Zhang C, Huang LS, Zhu R, Meng Q, Zhu S, Xu Y, Zhang H, Fang X, Zhang X, Zhou J, Schooley RT, Yang X, Huang Z, An J. PMID: 30978562; PMCID: PMC6677133.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    29. Hyperosmotic intraventricular drug delivery of DV1 in the management of intracranial metastatic breast cancer in a mouse model. J Clin Neurosci. 2019 Apr; 62:207-211. Krishnamurthy S, Li J, Bodman A, Zhang C, Yang Y, An J. PMID: 30678836; PMCID: PMC10158632.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    30. Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor. Molecules. 2018 Nov 20; 23(11). Zhang C, Zhang H, Huang LS, Zhu S, Xu Y, Zhang XQ, Schooley RT, Yang X, Huang Z, An J. PMID: 30463393; PMCID: PMC6278378.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    31. LC-MS/MS assay for the determination of a novel D-peptide antagonist of CXCR4 in rat plasma and its application to a preclinical pharmacokinetic study. J Pharm Biomed Anal. 2018 Nov 30; 161:159-167. Zhu Y, Yang S, Wang J, Mao Y, Xu Y, An J, Huang Z. PMID: 30165332; PMCID: PMC10264084.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    32. Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities. Eur J Med Chem. 2018 Sep 05; 157:380-396. Zhang H, Fang X, Meng Q, Mao Y, Xu Y, Fan T, An J, Huang Z. PMID: 30099258.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    33. Novel Bivalent and D-Peptide Ligands of CXCR4 Mobilize Hematopoietic Progenitor Cells to the Blood in C3H/HeJ Mice. Cell Transplant. 2018 08; 27(8):1249-1255. Mao Y, Meng Q, Song P, Zhu S, Xu Y, Snyder EY, An J, Huang Z. PMID: 29991278; PMCID: PMC6434473.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    34. Five ETS family members, ELF-1, ETV-4, ETV-3L, ETS-1, and ETS-2 upregulate human leukocyte-associated immunoglobulin-like receptor-1 gene basic promoter activity. Aging (Albany NY). 2018 Jun 18; 10(6):1390-1401. Cao Q, Yang S, Lv Q, Liu Y, Li L, Wu X, Qu G, He X, Zhang X, Sun S, Li B, An J, Hu T, Xue J. PMID: 29915163; PMCID: PMC6046229.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    35. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions. Exp Biol Med (Maywood). 2017 06; 242(11):1185-1197. Yan M, Li G, An J. PMID: 28474989; PMCID: PMC5478005.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    36. Design, synthesis, and biological characterization of novel PEG-linked dimeric modulators for CXCR4. Bioorg Med Chem. 2016 11 01; 24(21):5393-5399. Yang Y, Gao M, Zhang Q, Zhang C, Yang X, Huang Z, An J. PMID: 27658790; PMCID: PMC5498155.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    37. Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 Interaction. PLoS One. 2016; 11(3):e0152407. Zhang Q, Gao M, Luo G, Han X, Bao W, Cheng Y, Tian W, Yan M, Yang G, An J. PMID: 27014877; PMCID: PMC4807779.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    38. Biomodification of PCL Scaffolds with Matrigel, HA, and SR1 Enhances De Novo Ectopic Bone Marrow Formation Induced by rhBMP-2. Biores Open Access. 2015; 4(1):298-306. Bao W, Gao M, Cheng Y, Lee HJ, Zhang Q, Hemingway S, Luo Z, Krol A, Yang G, An J. PMID: 26309805; PMCID: PMC4497713.
      View in: PubMed   Mentions: 2  
    39. A novel CXCR4-selective high-affinity fluorescent probe and its application in competitive binding assays. Biochemistry. 2014 Aug 05; 53(30):4881-3. Yang Y, Zhang Q, Gao M, Yang X, Huang Z, An J. PMID: 25058910; PMCID: PMC4144712.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    40. Convenient Synthesis of Toxoflavin that Targets β-Catenin/Tcf4 Signaling Activities. Journal of Heterocyclic Chemistry. 2014; 51(3):594-597. Mao Y, Tian W, Huang Z, An J. View Publication.
    41. Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity. PLoS One. 2013; 8(11):e80183. Han X, Xu Y, Yang Y, Xi J, Tian W, Duggineni S, Huang Z, An J. PMID: 24265799; PMCID: PMC3827205.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    42. (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one sensitizes Escherichia coli persister cells to antibiotics. Appl Microbiol Biotechnol. 2013 Oct; 97(20):9145-54. Pan J, Xie X, Tian W, Bahar AA, Lin N, Song F, An J, Ren D. PMID: 24006079.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    43. A synthetic bivalent ligand of CXCR4 inhibits HIV infection. Biochem Biophys Res Commun. 2013 Jun 14; 435(4):646-50. Xu Y, Duggineni S, Espitia S, Richman DD, An J, Huang Z. PMID: 23688427; PMCID: PMC3752463.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    44. Development of a novel class of tubulin inhibitors with promising anticancer activities. Mol Cancer Res. 2013 Aug; 11(8):856-64. Xi J, Zhu X, Feng Y, Huang N, Luo G, Mao Y, Han X, Tian W, Wang G, Han X, Luo R, Huang Z, An J. PMID: 23666368.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    45. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4. Biochem Pharmacol. 2013 Feb 15; 85(4):507-13. Duggineni S, Mitra S, Noberini R, Han X, Lin N, Xu Y, Tian W, An J, Pasquale EB, Huang Z. PMID: 23253822; PMCID: PMC3807243.
      View in: PubMed   Mentions: 9     Fields:    Translation:Cells
    46. Novel aromatase inhibitors by structure-guided design. J Med Chem. 2012 Oct 11; 55(19):8464-76. Ghosh D, Lo J, Morton D, Valette D, Xi J, Griswold J, Hubbell S, Egbuta C, Jiang W, An J, Davies HM. PMID: 22951074; PMCID: PMC3469775.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    47. New Synthesis of Pyrvinium That inhibits the β-Catenin/Tcf4 Pathway. Heterocycles. 2012; 85(5):1179-1185. Mao Y, Lin N, Tian W, Huang Z, An J. View Publication.
    48. A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry. Biochemistry. 2012 Sep 11; 51(36):7078-86. Choi WT, Kumar S, Madani N, Han X, Tian S, Dong CZ, Liu D, Duggineni S, Yuan J, Sodroski JG, Huang Z, An J. PMID: 22897429; PMCID: PMC3476724.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    49. Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues. Biochemistry. 2012 Jul 31; 51(30):5951-7. Dong CZ, Tian S, Choi WT, Kumar S, Liu D, Xu Y, Han X, Huang Z, An J. PMID: 22779681; PMCID: PMC3891921.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    50. Design, synthesis, and biological evaluation of new diaminoquinazolines as β-catenin/Tcf4 pathway inhibitors. J Med Chem. 2012 Feb 09; 55(3):1346-59. Mao Y, Lin N, Tian W, Han X, Han X, Huang Z, An J. PMID: 22229647.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    51. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction. Biochemistry. 2012 Jan 17; 51(2):724-31. Tian W, Han X, Yan M, Xu Y, Duggineni S, Lin N, Luo G, Li YM, Han X, Huang Z, An J. PMID: 22224445.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    52. Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4). J Med Chem. 2012 Feb 09; 55(3):977-94. Choi WT, Duggineni S, Xu Y, Huang Z, An J. PMID: 22085380; PMCID: PMC3476736.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    Jing's Networks
    Concepts (217)
    Derived automatically from this person's publications.
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _